Annual Scientific Meeting Canadian Society of Internal Medicine November 1-4, 2006 · Calgary, Alberta

October 2006
Clinical & Investigative Medicine;Oct2006, Vol. 29 Issue 5, p314
Academic Journal
The article presents abstracts of medical research. The abstracts include "Incidence, Clinical Patterns and Outcomes of Gastrointestinal Bleeding in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome," "Systematic Review of Screening Questionnaires for Type 2 Diabetes," and "Intensity of Warfarin Therapy and Use of Interacting Medications in Long-term Care."


Related Articles

  • Embryonic stem cells: An alternative approach to developmental toxicity testing. Tandon, S.; Jyoti, S. // Journal of Pharmacy & Bioallied Sciences;Apr-Jun2012, Vol. 4 Issue 2, p96 

    Stem cells in the body have a unique ability to renew themselves and give rise to more specialized cell types having functional commitments. Under specified growth conditions, these cell types remain unspecialized but can be triggered to become specific cell type of the body such as heart,...

  • Highlights.  // Clinical Pharmacology & Therapeutics;Jun2012, Vol. 91 Issue 6, p954 

    The article offers information on medical studies related to pathogenesis, therapeutics and diseases. It states that Nanog dose regulation at the chromosome level is crucial for the acquisition of pluripotency in developmental stages. It says that the degree of epigenetic regulation in islets...

  • DoH 'slow to move on diabetes'.  // GP: General Practitioner;12/1/2003, p21 

    Great Britain government is dragging its feet over research on screening for people at high risk of diabetes, claims Diabetes UK. According to the diabetes NSF, the national screening committee should publish guidance in 2005 on targeted screening, such as for older people with a family history...

  • Tell Me More. Mettenburg, Julie // Countdown;Winter2000, Vol. 21 Issue 1, p40 

    Provides answers to readers' questions about diabetes. Barriers in the consideration of stem cell transplantation as a possible cure for diabetes; Research about genes called HLA markers which are associated with risk for diabetes.

  • Adult stem cells spur blood vessel growth in mice.  // Ophthalmology Times;11/15/2003, Vol. 28 Issue 22, p48 

    Investigates the effect of injecting adult stem cells from human blood into mice. Approach to safer and faster ways of testing stem cell-based therapies for many diseases in people; Provision of valuable safety check for scientists; Description of diabetic retinopathy.

  • Diabetic Cells.  // Technology Review;Jan/Feb2010, Vol. 113 Issue 1, p84 

    The article reports on a medical study which explores the role of stem cells from diabetic patients for further understanding the diabetes.

  • The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta- Analysis. Yazhen Zhang; Wenyi Chen; Bing Feng; Hongcui Cao // Aging & Disease;Feb2020, Vol. 11 Issue 1, p141 

    Diabetes mellitus (DM) is a chronic metabolic disease with high morbidity and mortality. Recently, stem cell-based therapy for DM has shown considerable promise. Here, we undertook a systematic review and meta-analysis of published clinical studies to evaluate the efficacy and safety of stem...

  • Diagnosis and monitoring of primary cytomegalovirus infection by antigenemia test in a stem cell doctor. Han, X.Y.; Anderlini, P.; Tarrand, J. // Bone Marrow Transplantation;9/15/2002, Vol. 30 Issue 6, p411 

    Discusses a case regarding the diagnosis and monitoring of primary cytomegalovirus infection by antigenemia test in a stem cell donor. Uses of cytomegalovirus antigenemia test; Medical history of the patient; Implication of the case.

  • Use of Circulating Galactomannan Screening for Early Diagnosis of Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients. Maertens, Johan; Van Eldere, Johan; Verhaegen, Jan; Verbeken, Erik; Verschakelen, Johny; Boogaerts, Marc // Journal of Infectious Diseases;11/1/2002, Vol. 186 Issue 9, p1297 

    Screening for galactomannan (GM) has been adopted by many European centers as part of the management plan for allogeneic stem cell transplant recipients. However, the temporal onset of GM antigenemia remains unknown. A series of allogeneic stem cell transplant recipients were monitored...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics